Hanall Biopharma's chart data is dated 2026-10-08. Recorded technical signals: MACD bullish cross. There are 1 published signal records.
Hanall Biopharma last closed at ₩44,100 (-3.71%) on 2026-10-08. Signals today: MACD bullish cross. Listed on KOSPI. Trailing 12 months PER is -89.7×. Its overall grade ranks 180 of 308 stocks in Healthcare.
About this company
Hanall Biopharma last closed at ₩44,100 (-3.71%) on 2026-10-08. Signals today: MACD bullish cross. Listed on KOSPI.
Details →Reported results
Position in sector
Healthcare · Overall B- · 180/308
Valuation grade D
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 유한양행Competitor
면역항체·바이오신약 개발에서 국내 주요 경쟁사
- 종근당Competitor
국내 바이오/신약 개발 경쟁사
- 삼성바이오로직스Related theme
바이오의약품 산업 전반에서 함께 주목받는 국내 대형 바이오 기업
ETFs holding this stock
HANARO 바이오코리아액티브 · KoAct 바이오헬스케어액티브 · TIME K바이오액티브
Details →About Hanall Biopharma
- What technical signals does Hanall Biopharma (009420) have?
- Hanall Biopharma current technical signals: MACD bullish cross.
- Is Hanall Biopharma a cup-and-handle pattern?
- No. Hanall Biopharma has no valid Cup signal right now.
- What published figures are available for Hanall Biopharma?
- Market cap: KRW 2.3T. Trailing 12 months PER: -89.7×. Latest quarter PBR: 13.82×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Hanall Biopharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.